• Dual human epidermal growth factor receptor 2 (HER2) blockade with trastuzumab and pertuzumab (TP) is a standard therapy of metastatic and localized HER2-positive breast cancer (BC), but its activity in breast cancer brain metastases (BCBM) is unknown.

    Patients with HER2-positive BCBM were identified from the Vienna Brain Metastasis…[Read more]

  • Terrell Carr became a registered member 5 days, 11 hours ago